SurModics, Inc. (SurModics) is a provider of drug delivery and surface modification technologies to the healthcare industry. The services provided by the Company include drug delivery technologies (coatings, micro particles and implants); surface modification coating technologies that impart lubricity, prohealing and biocompatibility capabilities, components for in vitro diagnostic test kits, and specialized surfaces for cell culture and microarrays. As of September 30, 2008, SurModics managed its business, through seven technology- and market-focused business units, which includes Drug Delivery, Ophthalmology, Hydrophilic Technologies, Regenerative Technologies, In Vitro Technologies, Orthopedics and Brokwood Pharmaceuticals. In September 2008, it acquired the CodeLink Activated Slide microarray business. In November 2008, it reorganized into four clinically and market-focused business units: Cardiovascular, Ophthalmology, In Vitro Technologies, and Brookwood Pharmaceuticals.